Agenus Doses First Cancer Patient with iNKT Cell Therapy
Go back to Agenus Doses First Cancer Patient with iNKT Cell Therapy| AGENUS (NASDAQ: AGEN) | Delayed: 3.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $7.49 | |||
| Open | $3.04 | 52 Week Low | $2.61 | |||
| Day High | $3.04 | P/E | N/A | |||
| Day Low | $3.04 | EPS | $-1.10 | |||
| Volume | 21 | |||||
